REVIEW 4 major objections 5 minor 5 cited by
Automated Hypothesis Validation with Agentic Sequential Falsifications
T0 review · 4 major / 5 minor · reviewed 2026-08-07 · deepseek-v4-flash
Pith's one-line read Free-form scientific hypotheses can be automatically validated with strict false-positive control.
desk verdict A genuinely useful integration of LLM agents with e-value sequential testing, but the abstract's 'strict Type-I control' outruns the evidence because the implication gate is an imperfect LLM relevance checker. read the letter →
The pith
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
The reading
What carries the argument
The machinery that carries the argument is the sequential e-value, a nonnegative random variable with expected value at most one under the null, together with the p-to-e calibrator $e_i = \kappa p_i^{\kappa-1}$. Because the product of conditional e-values is a nonnegative supermartingale (an e-process), the aggregated evidence $E_i$ is valid under optional stopping, and Markov's inequality transfers this validity into a Type-I error bound. This statistical skeleton is wrapped in two LLM agents—a design agent that proposes falsification tests and a ReAct execution agent that computes p-values—plus an LLM relevance checker whose job is to enforce Assumption 1 by discarding proposals that are not logically implied by the main hypothesis.
What would settle it
Construct a benchmark of main-null hypotheses where deliberately irrelevant sub-hypotheses are fed past the relevance checker (for example by loosening the acceptance threshold $r_0$ or by choosing hypotheses whose terminology overlaps with the checker's scoring rubric); if the product e-value crosses $1/\alpha$ and the hypothesis is rejected while the main null is true, Assumption 1 has failed and the Type-I guarantee no longer holds in practice. A direct version of this falsifier is already hinted at in the paper's POPPER-NoReleCheck ablation, which inflates Type-I error to 0.134–0.340, so the experiment would measure rejection rate as a function of checker threshold and show it exceeding $\alpha$.
Extended reading notes
Core claim
POPPER's central claim is that a free-form natural language hypothesis can be validated by treating it as a null hypothesis and sequentially testing its measurable implications, rather than trying to prove it directly. Each round, an LLM design agent proposes a falsification sub-hypothesis with an explicit null and alternative; a relevance checker filters proposals to enforce that the sub-null is implied by the main null; and an execution agent computes a valid p-value from existing data, simulations, or experiments. The p-values are converted to e-values with the calibrator $e_i = \kappa p_i^{\kappa-1}$, and the product $E_i = \prod_{s=1}^{i} e_s$ is the accumulated evidence. Theorem 4 shows that under Assumptions 1–3 this product is a valid e-value, so the rule “reject when $E \geq 1/\alpha$” rejects a true null with probability at most $\alpha$, even under optional stopping. The paper reports that this pipeline controls Type-I error at the nominal level across DiscoveryBench (86 hypotheses, six domains) and two TargetVal benchmarks, achieves higher power than error-controlled baselines, and matches nine human experts on complex biological hypotheses while running about ten times faster.
Load-bearing premise
Every sub-hypothesis tested must actually be implied by the main hypothesis, so that a false main hypothesis can never be “supported” by rejecting an irrelevant side claim; that logical link is enforced by an LLM relevance checker that the paper's own data show overstates implication strength.
Editorial extensions
If this is right
- Any hypothesis that survives a run of POPPER has accumulated product-e-value evidence above $1/\alpha$, and that evidence is valid under optional stopping: the user may decide to stop after seeing promising results without inflating the error bound.
- On the reported benchmarks, POPPER keeps empirical Type-I error at or below the nominal $\alpha=0.1$ (0.103±0.020 on DiscoveryBench, 0.082±0.046 on TargetVal-IL2, 0.085±0.028 on TargetVal-IFNG) while achieving the highest power among methods with controlled error.
- Comparison to nine PhD-level experts on TargetVal-IL2 shows comparable Type-I error and power, with a 9.7× speedup, providing evidence that automation does not sacrifice validation quality in this setting.
- Ablations show the relevance checker is load-bearing: removing it inflates Type-I error to 0.134±0.021, 0.340±0.139, and 0.300±0.113 on the three benchmarks, consistent with the theory that Assumption 1 is needed.
Reading between the lines
- The Type-I guarantee is conditional on Assumption 1, and since the paper reports 17.2% of failed runs as “Falsification Test Breaks Implication,” a fair reading implies that real-world error rates depend on how well the relevance checker is calibrated; tightening the checker threshold $r_0$ or adding human-in-the-loop verification of implication could close the gap between the 85% machine vs 77% h
- Because the system outputs a per-hypothesis e-value, the same e-values can be plugged into e-BH to control the false discovery rate across many hypotheses—an extension the paper notes as future work but does not test.
- A testable extension would be to use POPPER in a closed loop with LLM hypothesis generators, ranking candidate hypotheses by their terminal e-value; the framework would then act as a cheap empirical filter for hallucinated claims.
- The relevance checker's overestimation suggests that an adversarially chosen set of irrelevant sub-hypotheses could inflate rejections; stress-testing POPPER with such adversarial proposals would measure the practical robustness of the Type-I guarantee.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The paper proposes POPPER, an agentic LLM framework that validates free-form natural-language hypotheses by iteratively designing and executing falsification experiments. Each experiment yields a p-value under an LLM-chosen null sub-hypothesis, the p-values are converted to e-values through a calibrator, and the product is compared against 1/alpha with optional stopping. The authors prove a conditional Type-I error guarantee (Theorem 4) under three assumptions, instantiate the framework on biology, economics, and sociology benchmarks, and report a human-expert comparison. The central claimed contribution is that free-form hypotheses can be automatically and rigorously tested at scale while strictly controlling Type-I error.
Significance. If the guarantee held for the deployed system, this would be a significant step for automated scientific discovery: it combines a principled sequential e-value framework with LLM-driven experiment design and execution, ships public code, and includes both benchmark evaluations and an expert human study with qualitative trajectory analysis. The proof of Theorem 4 is a standard and correct e-process/supermartingale argument conditional on Assumptions 1-3. However, the paper's headline claim of strict Type-I error control is not supported for the automated system, because the assumption that the LLM-chosen sub-hypotheses are genuine implications of the main null is not established and the empirical certification criterion is too weak. The theoretical core is sound; the deployment-level claim needs substantial rework or reframing.
major comments (4)
- [Section 2.3, Assumption 1; Listing 4; Table 3; Appendix D; Figure 11] Strict Type-I error control is not established because Assumption 1 is not enforced by the relevance checker. The checker prompt (Listing 4) asks for a relevance score based on evidence strength, mechanistic connection, and predictive value, not for the logical implication 'H0 true implies h0_i true.' The paper's own measurements show the gate is leaky: Section 4.2 reports the checker labels 85% of proposals as strongly implied versus 77% for human annotators, and Appendix D attributes 17.2% of failed runs to 'falsification test breaks implication.' The false-positive trajectory in Figure 11 shows an accepted and executed test whose implementation violates implication. When a non-implied sub-test is rejected with a small p-value, it can push the product e-value past 1/alpha while the main null is true. The abstract's 'strict Type-I error control' is therefore unsupported for the automated system; Theorem 4 remains valid only conditionally.
- [Table 3 and Section 4.1] The empirical certification of Type-I error control is not statistically sound. A method is declared to control error if the nominal alpha 'falls within 1 standard deviation' of the estimated rate, but the relevant quantity is an upper bound on the error rate, not an interval centered at the estimate. In Table 3, the DiscoveryBench estimate is 0.103 +/- 0.020 for alpha = 0.10, which is above the nominal level; the criterion merely declares this acceptable because 0.10 is within one standard deviation. With only 5 runs, the standard error itself is poorly determined. Report a one-sided upper confidence bound or a formal test of the null that the error rate is at most alpha, and discuss the multiple-comparison issue across the three benchmarks.
- [Section 3, Assumption 2; Listing 2] The adaptive behavior of the execution agent is difficult to reconcile with Assumption 2. Assumption 2 requires that the test function f_i and sub-hypothesis h_i be selected using only past data and metadata, not the data in the current dataset. But the ReAct execution agent is described as inspecting raw data and then selecting suitable statistical tests 'based on the data distribution,' and it iteratively fixes errors and changes procedures after observing intermediate results. If the test procedure is not fixed before seeing the current data, conditional p-value validity under h0_i is not guaranteed. Please clarify exactly which parts of the analysis are pre-registered, or provide an argument that the adaptive procedure still yields conditionally valid p-values.
- [Equation (1), Section 3, and Table 3] The main empirical results are not reproducible from the manuscript because the values of the calibrator exponent kappa and the relevance threshold r0 (also called tau in Algorithm 1) are never reported. The sensitivity analysis in Figure 4 varies alpha and the number of tests but not kappa, even though Equation (1) shows that kappa directly controls the e-value magnitude and hence power and error control. Please report the exact values used for all free parameters and include a sensitivity analysis over kappa.
minor comments (5)
- [Introduction, paragraph 4] The word 'aggergation' should be 'aggregation.'
- [Appendix D] The phrase 'labaled automatically' should read 'labeled automatically.'
- [Appendix H] The word 'frameowkr' should be 'framework.'
- [Appendix A.2, proof of Theorem 4] The word 'filteration' should be 'filtration.'
- [Section 4.2 and Appendix I] The text references 'Listing 4' for the relevance checker prompt, but the prompts appear in Appendix I; the cross-reference should say Appendix I or list the prompt within the main text.
Circularity Check
No circularity: the Type-I guarantee is a standard conditional e-value supermartingale result, and the agentic components are validated against external benchmarks and human experts rather than being fitted to their own outputs.
full rationale
The derivation chain in Section 2.3 is conditional and self-contained: Assumptions 1-3 define logical implication, sequential validity, and optional stopping; Theorem 4 then follows from Doob's optional stopping and Markov's inequality as an e-value supermartingale argument, and the proof is supplied in Appendix A.2. The p-to-e calibrator in Eq. (1) is attributed to the external works of Vovk & Wang (2021) and Grunwald et al. (2020), not to a fitted parameter or to the authors' own prior results. None of the reported Type-I error rates, power numbers, or human-study comparisons is obtained by renaming a fitted quantity as a prediction; the empirical estimates in Table 3 are measured on negative examples generated by permutation and on positive benchmark hypotheses, and the comparison in Figure 2 is against external human annotators. The only self-citation (Li et al. 2024a) is used to contrast POPPER with a different hypothesis-testing framework and is not load-bearing for any theorem or empirical claim. The paper's own disclosures about the relevance checker - that it labels 85% of proposals as 'strongly implied' versus 77% for humans, and that 17.2% of failed runs are 'Falsification Test Breaks Implication' - are a validity risk for Assumption 1, not a circular reduction: they show that an assumption may be empirically violated, but the derivation from the assumption to the error bound is not equivalent to its inputs. Section C's limitation that Type-I control does not guarantee true discoveries is likewise a scope caveat, not a circular step. Overall, the central guarantee is a standard external mathematical result with explicitly stated assumptions, and the agentic contributions are evaluated against independent benchmarks, so the analysis finds no significant circularity.
Assumptions & free parameters
free parameters (2)
- kappa (p-to-e calibrator exponent) =
0.5 (inferred from the worked example; not stated in the main text)
- r0 (relevance threshold) =
not specified in text
assumptions (4)
- domain assumption Assumption 1 (Implication): if the main null H0 is true, then each proposed null sub-hypothesis h0_i is also true
- domain assumption Assumption 2 (Sequential information): each e-value is conditionally valid given prior data, E[ei | D_{i-1}] <= 1 under h0_i
- domain assumption Assumption 3 (Optional stopping): stopping time is adapted to the data filtration
- standard math E-value supermartingale property and Doob's optional stopping theorem
Cite this review
Pith. "Pith review of Automated Hypothesis Validation with Agentic Sequential Falsifications." pith.science (2026). https://pith.science/paper/4LSU27AZ
@misc{pith2026250209858,
author = {Pith},
title = {Pith review of: Automated Hypothesis Validation with Agentic Sequential Falsifications},
year = {2026},
howpublished = {\url{https://pith.science/paper/4LSU27AZ}},
note = {Machine review of arXiv:2502.09858}
}
read the original abstract
Hypotheses are central to information acquisition, decision-making, and discovery. However, many real-world hypotheses are abstract, high-level statements that are difficult to validate directly. This challenge is further intensified by the rise of hypothesis generation from Large Language Models (LLMs), which are prone to hallucination and produce hypotheses in volumes that make manual validation impractical. Here we propose Popper, an agentic framework for rigorous automated validation of free-form hypotheses. Guided by Karl Popper's principle of falsification, Popper validates a hypothesis using LLM agents that design and execute falsification experiments targeting its measurable implications. A novel sequential testing framework ensures strict Type-I error control while actively gathering evidence from diverse observations, whether drawn from existing data or newly conducted procedures. We demonstrate Popper on six domains including biology, economics, and sociology. Popper delivers robust error control, high power, and scalability. Furthermore, compared to human scientists, Popper achieved comparable performance in validating complex biological hypotheses while reducing time by 10 folds, providing a scalable, rigorous solution for hypothesis validation.
Figures
Figures from the paper (8 more)
Forward citations
Cited by 5 Pith papers
-
Auditing Discovery Claims: A Two-Sided Criterion for Agentic Science, with the Negative Side Decidable
A two-sided audit with a formally decidable negative side shows a single-oracle RNA design claim collapses from 43/60 to 1/60 under a three-predictor panel, while two AI-written operators survive a held-out judge.
-
Pramana: A Composable, Domain-Specific Backend for Empirical Networking Research
One intent-specification language can express all 255 networking data-generation intents mined from 66 papers, and a proof-of-concept backend already covers 34 percent—more than twice the best existing tool.
-
Automating Exploratory Multiomics Research via Language Models
An LLM-based system called PROTEUS automatically explores clinical multiomics datasets and generates 360 data-driven hypotheses without human intervention, with mixed but mostly supportive external validation.
-
BioDSA-1K: Benchmarking Data Science Agents for Biomedical Research
BioDSA-1K is a large, publication-grounded benchmark for evaluating AI agents on biomedical hypothesis validation, including non-verifiable cases.
-
A Multi-Layered Framework for Modeling Human Biology: From Basic AI Agents to a Full-Body AI Agent
The paper proposes, but does not implement or validate, a multi-agent AI framework for cross-scale modeling of human biology from molecules to whole body, with sketches of metastasis scoring and drug development.
Reference graph
Works this paper leans on
-
[1]
Read the main hypothesis and the sub-hypothesis test carefully
-
[2]
Choose the relevance score from the rubric that best matches the relationship
-
[3]
Listing 4: Relevance Checker System Prompt You are a helpful assistant trained to help scientists summarize their experiment observations
Explain your reasoning for selecting this score, referring to evidence strength, mechanistic connection, and predictive value of the sub-hypothesis test results. Listing 4: Relevance Checker System Prompt You are a helpful assistant trained to help scientists summarize their experiment observations. You have observed a sequential falsification test proced...
-
[4]
GRAP2 expression does not differ between tissues that are high IL-2 expressers versus those that are low IL-2 expressers
Failure to observe this difference would be potential evidence to falsify the main hypothesis. Null Sub-Hypothesis h_0 (tentative): "GRAP2 expression does not differ between tissues that are high IL-2 expressers versus those that are low IL-2 expressers." Alternate Sub-Hypothesis h_1 (tentative): "GRAP2 expression is significantly higher (or lower) in tis...
-
[6]
Estimate the probability of this evidence under the alternative hypothesis, P(data|h_1)
-
[7]
Estimate the probability of this evidence under the null hypothesis, P(data|h_0). Follow this rigorous rubric to evaluate estimation precision, focusing on both theoretical grounding and accuracy in likelihood estimation: - **0.1**: Extremely poor estimate, lacks theoretical grounding; estimation is inconsistent with evidence and does not consider hypothe...
-
[8]
**Critique**: Evaluate the estimation’s reasonableness, theoretical rigor, and alignment with this rubric
-
[9]
Tissue-Wide Expression Correlation Test between GRAP2 and IL-2
**Reflect**: Identify specific improvements to enhance accuracy and theoretical grounding based on critique. - If the estimation achieves a rigorous standard (e.g., reaching 0.9 or 1.0), return the final estimates: - P(data|h_1) = [final value] - P(data|h_0) = [final value] - If refinement is needed, improve or propose a new estimation, then proceed to th...
Show all 96 references
-
[10]
From df_gtex_tissue_gene_tpm, identify tissues with relatively high IL-2 expression and those with relatively low (or no) IL-2 expression
-
[11]
Compare GRAP2 expression levels between these two groups of tissues (e.g., via a two-sample t-test)
-
[12]
If GRAP2 truly helps regulate IL-2, one would expect significantly higher GRAP2 expression in tissues where IL-2 is robustly expressed
-
[14]
Gene GRAP2 regulates the production of Interleukin-2
CRITICISM: Does the test become null if the main hypothesis ("Gene GRAP2 regulates the production of Interleukin-2") is null? If GRAP2 truly has no regulatory role on IL-2, we would not expect GRAP2 expression to track IL-2 expression across tissues. Hence in that scenario, th...
-
[15]
IL-2 rich
REFLECTION AND POSSIBLE IMPROVEMENTS: The proposed test is fairly straightforward, but still biologically meaningful. It differs from a simple correlation test by explicitly focusing on whether GRAP2 is enriched in tissues that produce IL-2. The grouping (high vs. low IL-2 tis...
-
[16]
Tissue-Wide Expression Correlation Test (GRAP2 vs IL-2 directly)
-
[17]
IL-2 Pathway Co-expression Test for GRAP2
Essential Expression Overlap Test (presence/absence) - Previously failed test: Tissue-Specific Expression Contrast Test (high vs low IL -2 groups). - The new proposal is different: It tests correlation of GRAP2 with IL-2 signaling components (e.g. IL2RA, IL2RB, JAK3, STAT5), n...
-
[18]
A simple correlation of GRAP2 and IL2 expression across tissues
-
[19]
A presence/absence (Fisher exact) approach
-
[20]
low-IL2 tissues
A contrast of GRAP2 across high- vs. low-IL2 tissues
-
[21]
IL-2 pathway co-expression test,
A broad co-expression test of GRAP2 with IL2-signaling genes. In contrast, the newly proposed test focuses on controlling for a housekeeping gene to rule out the trivial possibility that GRAP2 and IL2 are simply co- varied because of global transcription differences between ti...
-
[22]
If GRAP2 does not in fact regulate IL2, then any correlation computed across tissues would be comparable to random
Does the test become null if the main hypothesis is null? Yes. If GRAP2 does not in fact regulate IL2, then any correlation computed across tissues would be comparable to random. Hence, the test’s sub- hypothesis (that GRAP2 is more correlated with IL2 than random genes) would...
-
[23]
None used a random-gene control distribution
Is this test redundant with (or overly similar to) existing or failed tests? Existing tests involved direct correlation between GRAP2 and IL2 or presence/ absence overlap, as well as partial-correlation controlling for housekeeping genes. None used a random-gene control distri...
-
[24]
if main hypothesis is null, then sub-hypothesis is also null
Is the test answerable from the given data, and does it avoid the previously failed proposals? Yes. We can implement this test with df_gtex_tissue_gene_tpm by extracting GRAP2 expression, IL2 expression, and expression for all other genes. It is not one of the cited failed tes...
-
[25]
LCP2 regulates IL-2 production
Validity: If the main hypothesis "LCP2 regulates IL-2 production" is null, would this test also be null? - Not necessarily. Physical interaction is not required for regulation. A gene can regulate another gene’s production through indirect pathways without physical protein int...
-
[26]
Data availability: - We have protein interaction data (df_affinity_capture_ms, df_two_hybrid, etc.) - However, we need gene IDs for both LCP2 and IL-2 to use these datasets
-
[27]
Redundancy: - No redundancy issues as there are no existing tests yet Reflection: 45 Automated Hypothesis Validation with Agentic Sequential Falsifications We need a better test that:
-
[28]
Has proper logical implication (if main hypothesis is null, test should be null)
-
[29]
Uses available data more effectively
-
[30]
Is more directly related to regulation of production Let me propose a revised test: Revised Test Proposal: (1) Name: Expression Correlation Test (2) Test description: Test if LCP2 expression levels correlate with IL-2 expression levels across tissues in GTEx data (3) Null sub-...
-
[31]
This satisfies the validity requirement
Validity: If LCP2 doesn’t regulate IL-2 production (null main hypothesis), then there should indeed be no correlation in expression (null sub-hypothesis). This satisfies the validity requirement
-
[32]
Data availability: - We have df_gtex_tissue_gene_tpm which contains gene expression data across tissues - We can calculate correlation between LCP2 and IL-2 expression
-
[33]
I recommend proceeding with this final test definition
Implementation feasibility: - This test can be implemented using standard correlation analysis - P-value can be computed from the correlation test This revised test appears to be valid, implementable, and logically sound. I recommend proceeding with this final test definition....
-
[34]
Direct Variable Connection: The test directly examines the relationship between the two key variables in the main hypothesis - LCP2 and IL-2
-
[35]
Mechanistic Insight: While correlation doesn’t prove causation, a strong correlation would provide substantial supporting evidence for a regulatory relationship, especially across different tissues
-
[36]
The test results would significantly impact our confidence in the main hypothesis
Predictive Value: If LCP2 regulates IL-2 production, we would expect to see a significant positive correlation between their expression levels. The test results would significantly impact our confidence in the main hypothesis. The reason this doesn’t receive a 1.0 score is tha...
-
[37]
Physical protein interactions don’t always imply regulatory relationships
Causality Check: If the main hypothesis (LCP2 regulates IL-2) is null, would this sub-hypothesis also be null? - Not necessarily. Physical protein interactions don’t always imply regulatory relationships. Two proteins can interact without one regulating the other’s 47 Automate...
-
[38]
Data Availability: - We have protein interaction data (df_affinity_capture_ms, df_two_hybrid, etc.) - However, we need to ensure we can specifically identify IL-2 related proteins
-
[39]
- It examines a different molecular mechanism
Redundancy: - This test is not redundant with the previous expression correlation test. - It examines a different molecular mechanism. Reflection: Let me refine this test to better align with regulatory relationships: Refined Proposal: (1) Name: LCP2 Regulatory Network Analysi...
-
[40]
This provides a clear mechanistic link to how LCP2 might influence IL-2 production
Mechanistic Connection: The test directly investigates the molecular mechanisms through which LCP2 could regulate IL-2 production by examining physical protein interactions with known IL-2 regulators. This provides a clear mechanistic link to how LCP2 might influence IL-2 production
-
[41]
If LCP2 physically interacts with known IL-2 regulators, this would provide substantial support for its role in IL-2 regulation
Evidence Strength: Using high-confidence protein interaction data offers strong, direct evidence of potential regulatory relationships. If LCP2 physically interacts with known IL-2 regulators, this would provide substantial support for its role in IL-2 regulation
-
[42]
Number of LCP2 physical interactions: {len(lcp2_interactions)}
Predictive Value: The results would significantly impact our confidence in the main hypothesis. If LCP2 shows interactions with established IL-2 regulators, it strongly suggests a regulatory role. Conversely, absence of such interactions would significantly weaken the main hyp...
-
[43]
We found 3 high-confidence physical interactions for LCP2 in the human interactome
-
[44]
Out of these 3 interactions, 0 were with known IL-2 pathway genes
-
[45]
We performed a binomial test to determine if this observation was statistically significant, comparing against the null expectation based on the proportion of IL-2 related genes in the network
-
[46]
The data does not support the alternate hypothesis that LCP2 shows significant physical interactions with established IL-2 transcriptional regulators or upstream signaling proteins
The test yielded a p-value of 1.00e+00, indicating no significant enrichment or depletion of IL-2 pathway interactions Final Answer: We fail to reject the null hypothesis with a p-value of 1.00e+00. The data does not support the alternate hypothesis that LCP2 shows significant...
-
[47]
This satisfies the key requirement
Logical Validity: If the main hypothesis (LCP2 regulates IL-2 production) is null , then genetic variants affecting LCP2 should indeed show no association with IL -2-dependent phenotypes. This satisfies the key requirement
-
[48]
51 Automated Hypothesis Validation with Agentic Sequential Falsifications
Non-redundancy: This test is distinct from previous tests: - Round 1 looked at expression correlation - Round 2 examined protein interactions This test looks at genetic evidence through variant analysis. 51 Automated Hypothesis Validation with Agentic Sequential Falsifications
-
[49]
Data Availability: Yes, we can implement this using: - df_genebass_pLoF_filtered for loss of function variants - df_genebass_missense_LC_filtered for missense variants These contain gene-phenotype associations
-
[50]
Reflection: The test could be improved by:
Strength: This test provides causal evidence through genetic variation, which is stronger than correlation or interaction evidence. Reflection: The test could be improved by:
-
[51]
Being more specific about which immune phenotypes to look at
-
[52]
Clarifying the statistical threshold for significance
-
[53]
Specifying how to combine evidence across different variant types Refined Proposal: (1) Name: LCP2 Variant-Immune Phenotype Association Test (2) Test description: Test if LCP2 loss-of-function and missense variants are significantly associated with autoimmune conditions and T-...
-
[54]
Mechanistic Connection: The test examines LCP2 genetic variants and their association with immune phenotypes that are known to be IL-2 dependent, providing a direct mechanistic link to the main hypothesis about LCP2’s role in IL-2 regulation
-
[55]
Evidence Strength: By using genetic variants (loss-of-function and missense) in LCP2 and examining their association with IL-2-dependent phenotypes, the test provides strong genetic evidence for the functional relationship between LCP2 and IL-2 production
-
[56]
Number of pLoF variants:
Predictive Value: If LCP2 truly regulates IL-2 production, we would expect LCP2 variants to be associated with autoimmune and T-cell related phenotypes, making this test highly predictive. The use of GeneBASS database adds statistical rigor to the analysis. The score is 0.8 ra...
-
[57]
The direction of effect (BETA) to ensure it aligns with our biological expectations
-
[58]
Full statistics for top association:
The sample size and test power -------------------------------- Action: python_repl_ast Action Input: # Look at the complete statistics for our top finding print("Full statistics for top association:") print(significant_result[[’pheno_description’, ’BETA_Burden’, ’SE_Burden’]]...
-
[59]
We found associations between LCP2 variants and immune-related phenotypes, particularly with lymphocyte percentage
-
[60]
Despite the strong effect size and biologically plausible direction of effect, we must maintain statistical rigor
The strongest association showed: - Minimum p-value = 6.66e-05 (uncorrected) - Bonferroni corrected p-value = 9.42e-02 - Positive effect (BETA = 0.014855) - Strong effect size (t-statistic 4.0) However, after multiple testing correction, we technically cannot reject the null h...
-
[61]
Therefore, the test doesn’t fully satisfy the crucial property that null main hypothesis implies null sub-hypothesis
Causality Direction: If the main hypothesis (LCP2 regulates IL2) is null, this test might still show significance if there’s a third factor affecting both genes, or if IL2 regulates LCP2. Therefore, the test doesn’t fully satisfy the crucial property that null main hypothesis ...
-
[62]
Data Availability: Looking at the provided data sources, while we have eQTL data from UKBB (df_eqtl_ukbb), we don’t have comprehensive regulatory region annotations or IL2 genomic location data to properly implement this test
-
[63]
expression correlation or protein interactions), it may partially overlap with the variant-phenotype associations tested in Round 3
Non-redundancy: While this test examines a different aspect than previous tests ( genetic regulation vs. expression correlation or protein interactions), it may partially overlap with the variant-phenotype associations tested in Round 3. Reflection: We need a test that:
-
[64]
Has stronger directional causality aligned with the main hypothesis
-
[65]
Can be clearly implemented with available data
-
[66]
Null sub-hypothesis h_0: LCP2 expression in immune tissues is not significantly higher than in non-immune tissues
Provides unique evidence Let me propose a refined test: Name: LCP2 Immune Cell-Specific Expression Test Test description: Test if LCP2 expression is specifically elevated in immune cell types where IL2 production is known to occur (e.g., T cells) compared to other tissues usin...
-
[67]
Causality: If the main hypothesis is null, this test would also be null because if LCP2 doesn’t regulate IL2, there’s no requirement for it to be specifically expressed in IL2-producing cells
-
[68]
Data Feasibility: We can implement this using df_gtex_tissue_gene_tpm data
-
[69]
Non-redundancy: This test provides unique tissue-specific evidence different from previous tests
-
[70]
This refined test appears to meet all our criteria
Biological Relevance: This test aligns with the biological context of IL2 regulation. This refined test appears to meet all our criteria. Relevance Checker Proposed falsification test passes relevance check: Proposal: Main hypothesis: Gene LCP2 regulates the production of Inte...
-
[71]
56 Automated Hypothesis Validation with Agentic Sequential Falsifications
Mechanistic Connection: Since IL-2 is primarily produced by immune cells ( especially T cells), testing LCP2’s expression pattern in immune vs non-immune tissues directly addresses a key mechanistic aspect of the hypothesized regulatory relationship. 56 Automated Hypothesis Va...
-
[72]
However, it doesn’t directly prove regulation, which is why it’s not scored as 1.0
Evidence Strength: The test provides strong circumstantial evidence - if LCP2 is specifically expressed in IL-2-producing immune cells, it supports its potential role as a regulator. However, it doesn’t directly prove regulation, which is why it’s not scored as 1.0
-
[73]
If LCP2 is not expressed in IL-2-producing cells, it would be difficult to support its role as a direct regulator
Predictive Value: The test results would significantly impact confidence in the main hypothesis. If LCP2 is not expressed in IL-2-producing cells, it would be difficult to support its role as a direct regulator. Conversely, specific expression in these cells would strengthen t...
-
[74]
The LCP2 gene is actually present in the dataset
-
[75]
We can properly identify immune vs non-immune tissues
-
[76]
Number of unique genes: {len(unique_genes)}
We have enough samples for a meaningful statistical comparison Let me first check if LCP2 is in the dataset. -------------------------------- Action: python_repl_ast Action Input: # Check unique genes in the dataset unique_genes = df_gtex_tissue_gene_tpm[’Gene’].unique() print...
-
[77]
Mann-Whitney U test statistic: {stat}
Cells - EBV-transformed lymphocytes Action: python_repl_ast Action Input: # Define immune tissues immune_tissues = [’Whole Blood’, ’Spleen’, ’Cells - EBV-transformed lymphocytes’] # Create two groups for comparison immune_expression = lcp2_data[lcp2_data[’Tissue’].isin(immune_...
-
[78]
Therefore, this test doesn’t necessarily become null when the main hypothesis is null
Main hypothesis nullity implication: If RAB39A does not regulate IL-2 production, it could still be highly expressed in immune tissues for other functions. Therefore, this test doesn’t necessarily become null when the main hypothesis is null. This violates the key requirement
-
[79]
Data availability: While we have GTEx tissue expression data ( df_gtex_tissue_gene_tpm), the tissue categories might not be granular enough to specifically identify immune tissues
-
[80]
RAB39A-IL2 Expression Correlation Test
Redundancy: This test partially overlaps with the failed "RAB39A-IL2 Expression Correlation Test" as both use expression patterns. Reflection: We need a test that:
-
[81]
Has stronger logical connection to the regulatory relationship
-
[82]
Becomes null when the main hypothesis is null
-
[83]
Uses different data types than previous tests
-
[84]
Is answerable with available data New Proposal: (1) Name: RAB39A Genetic Variant Impact on IL-2 QTL Test (2) Test description: Test if genetic variants near RAB39A are significant QTLs for IL-2 related immune traits in the UK Biobank eQTL data (3) Null sub-hypothesis h_0: Gene...
-
[85]
This satisfies the nullity requirement
Main hypothesis nullity: If RAB39A doesn’t regulate IL-2, genetic variants affecting RAB39A should indeed show no QTL effects on IL-2 related traits. This satisfies the nullity requirement
-
[86]
Data availability: We have eQTL data from UK Biobank (df_eqtl_ukbb) and variant information (df_variant_table)
-
[87]
Non-redundancy: This test uses different data types (QTL) compared to previous tests that used GeneBASS and protein interactions
-
[88]
This refined test appears to meet all requirements
Implementation feasibility: The test can be implemented using the provided datasources. This refined test appears to meet all requirements. Relevance Checker Proposed falsification test passes relevance check: Proposal: Main hypothesis: Gene RAB39A regulates the production of ...
-
[89]
Direct genetic link: The test examines genetic variants specifically near RAB39A and their relationship to IL-2 related traits, which directly addresses the proposed regulatory relationship in the main hypothesis
-
[90]
62 Automated Hypothesis Validation with Agentic Sequential Falsifications
Population-level evidence: Using UK Biobank eQTL data provides robust, population -scale evidence that could substantiate a regulatory relationship between RAB39A and IL-2. 62 Automated Hypothesis Validation with Agentic Sequential Falsifications
-
[91]
Mechanistic insight: QTL associations would suggest a genetic basis for the regulatory relationship, though it doesn’t fully elucidate the exact molecular mechanism
-
[92]
Number of RAB39A eQTLs:
High predictive value: If significant QTL associations are found, it would strongly support (though not definitively prove) the main hypothesis. Conversely , absence of associations would significantly challenge it. The score is 0.8 rather than 1.0 because while the test provi...
-
[93]
Multiple independent eQTL signals (4 different variants)
-
[94]
These are found in immune cells (neutrophils)
-
[95]
The associations are highly significant with the strongest p-value at 2.81e-13
-
[96]
sufficient evidence - PASS
The observation is in a relevant tissue type for IL-2 related immune traits 64 Automated Hypothesis Validation with Agentic Sequential Falsifications We can reject the null hypothesis that genetic variants near RAB39A show no significant QTL associations with IL-2 related immu...
-
[108]
discovery
URL https://aclanthology.org/2023. acl-long.108. Huang, L., Yu, W., Ma, W., Zhong, W., Feng, Z., Wang, H., Chen, Q., Peng, W., Feng, X., Qin, B., et al. A survey on hallucination in large language models: Principles, taxon- omy, challenges, and open questions. ACM Transactions...
2024 arXiv
-
[2021]
Baek, J., Jauhar, S
URL https://proceedings.mlr.press/ v139/alet21a.html. Baek, J., Jauhar, S. K., Cucerzan, S., and Hwang, S. J. Researchagent: Iterative research idea generation over scientific literature with large language models, 2024. URL https://arxiv.org/abs/2404.07738. Benjamini, Y . Sel...
2024 arXiv
Reviewed August 7, 2026 · model on record in the stance chip above.
Discussion (0). Sign in to comment.